Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
Sales | 193 | 1,203 | 3,598 | 15,158 | 134 |
Gross Profit | 193 | 1,203 | 3,598 | 15,158 | 134 |
Operating Expenses | 7,335 | 8,435 | 9,721 | 6,691 | 4,755 |
Operating Income | -7,142 | -7,232 | -6,123 | 8,467 | -4,621 |
Interest Expense | 468 | 369 | 413 | 531 | 626 |
Other Income | -996 | -9 | -49 | -22 | -209 |
Pre-tax Income | -8,606 | -7,610 | -6,585 | 7,914 | -5,456 |
Income Tax | N/A | 100 | N/A | N/A | N/A |
Net Income Continuous | -8,606 | -7,710 | -6,585 | 7,914 | -5,456 |
Net Income | $-8,606 | $-7,710 | $-6,585 | $7,914 | $-5,456 |
EPS Basic Total Ops | -1.30 | -1.30 | -1.00 | 1.40 | -1.00 |
EPS Basic Continuous Ops | -1.29 | -1.33 | -1.03 | 1.39 | -0.99 |
EPS Diluted Total Ops | -1.30 | -1.30 | -1.00 | 1.40 | -1.00 |
EPS Diluted Continuous Ops | -1.29 | -1.33 | -1.03 | 1.39 | -0.99 |
EBITDA(a) | $-7,130 | $-7,224 | $-6,340 | $8,564 | $399 |